CORALVILLE, IA – Integrated DNA Technologies (IDT), the world leader in oligonucleotide synthesis, has extended its proven expertise in oligo research, development and production to clinical and commercial OEM customers. Its Clinical and Commercial Manufacturing (CCM) facility is dedicated to the GMP production of oligos for diagnostic use. With the need for fully compliant oligos […]
IRVINE, Calif. – CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into a strategic partnership with Clarient, Inc., a GE Healthcare Company, that allows Clarient the right to commercialize the CombiMatrix DNAarray™ product portfolio. The DNAarray tests are based on aCGH technology, which provides physicians a comprehensive genomic profile of solid cancer tumors and […]
ROCKVILLE, Maryland and SEOUL, Korea – Seegene today launched its strategic push into personalized medicine by announcing a partnership with Samsung Medical Center to co-develop molecular diagnostics (MDx) for cancer. In this partnership Seegene will bring its molecular diagnostic technology leadership and Samsung Medical Center brings its clinical expertise and disease pathology to the development […]
MONTREAL – At the 2011 Annual Meeting of the Canadian Association for Clinical Microbiology and Infectious Diseases (CACMID), the companies i2A Canada and Bruker Ltd. announced together that they have met the relevant Health Products and Food Branch (HPFB) of Health Canada regulations for the Bruker IVD MALDI Biotyper, and that this product is now […]
IRVINE, Calif. – CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and genes used to classify and assist in the treatment of cancer and developmental disorders, announced today that it has closed its private placement, in which it sold $6.7 million of newly issued shares of its […]
Penzberg, Germany – Roche Joins in Spanish Research Cooperation for Personalized Treatment of Hepatitis B and C Roche Diagnostics (SIX: RO, ROG; OTCQX: RHHBY) is cooperating with the Spanish Vall d’Hebron Institute of Research (VHIR), the Networking Biomedical Research Centre in Liver and Digestive Diseases (CIBEREHD), and the software producer Advanced Biological Laboratories Therapy Edge […]
HOPKINTON, Mass. – Caliper Life Sciences, Inc. (NASDAQ: CALP), a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services (CDAS) unit has formed a research collaboration with Denver-based Catholic Health Initiatives (CHI), one of the nation’s largest health systems. The health care system’s […]
IPSWICH, Mass. and SAN DIEGO – New England Biolabs, Inc. (NEB) and Sequenom, Inc. (SQNM: 6.63 +0.14 +2.16%) jointly announce that they have signed a licensing and co-marketing agreement to commercialize research tools for epigenetics. This agreement is the result of a research collaboration between the two companies that has culminated in the development of […]
RainDance Technologies, Inc. today announced the commercial availability of the HLASeq™ Research Screening Panel, a comprehensive genetic screening solution for human leukocyte antigen (HLA) and major histocompatibility complex (MHC) research using next-generation sequencing technology. The announcement was made at the annual American Association for Cancer Research (AACR) meeting in Orlando, Florida. The HLA super locus […]
Venlo, the Netherlands and Melbourne, Australia – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has reached an agreement to acquire Cellestis Limited (CST:AU) for approximately A$341 million (US$355 million) in cash, providing QIAGEN with access to a novel “pre-molecular” technology that offers a new dimension in disease detection not currently possible with other diagnostic […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
